These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10074620)
21. Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors: the Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético). Martínez C; Gomez V; Tomás JF; Parody R; Sureda A; Sanz G; Cañizo C; Díez JL; Boqué C; Bone Marrow Transplant; 2005 Aug; 36(4):301-6. PubMed ID: 15968278 [TBL] [Abstract][Full Text] [Related]
22. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D; Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723 [TBL] [Abstract][Full Text] [Related]
23. Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation. Schaich M; Schäkel K; Illmer T; Ehninger G; Bornhäuser M Ann Hematol; 2003 May; 82(5):303-4. PubMed ID: 12707720 [TBL] [Abstract][Full Text] [Related]
25. Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis. Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin R; Martinelli G; Baccarani M Bone Marrow Transplant; 2007 Feb; 39(3):189-91. PubMed ID: 17211436 [No Abstract] [Full Text] [Related]
26. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report. Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598 [TBL] [Abstract][Full Text] [Related]
27. Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia. Qazilbash MH; Qu Z; Hosing C; Couriel D; Donato M; Giralt S; Champlin R Am J Hematol; 2005 Sep; 80(1):43-5. PubMed ID: 16138357 [TBL] [Abstract][Full Text] [Related]
28. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome. De Souza CA; Vigorito AC; Ruiz MA; Nucci M; Dulley FL; Funcke V; Tabak D; Azevedo AM; Byington R; Macedo MC; Saboya R; Penteado Aranha FJ; Oliveira GB; Zulli R; Martins Miranda EC; Azevedo WM; Lodi FM; Voltarelli JC; Simões BP; Colturato V; De Souza MP; Silla L; Bittencourt H; Piron-Ruiz L; Maiolino A; Gratwohl A; Pasquini R Haematologica; 2005 Feb; 90(2):232-7. PubMed ID: 15710577 [TBL] [Abstract][Full Text] [Related]
29. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility]. Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705 [TBL] [Abstract][Full Text] [Related]
30. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR. Hamadani M; Martin LK; Benson DM; Copelan EA; Devine SM; Hofmeister CC Bone Marrow Transplant; 2007 Feb; 39(4):249-51. PubMed ID: 17290281 [No Abstract] [Full Text] [Related]
31. [Chronic myelogenous leukemia and blood stem cell transplantation]. Masaoka T Gan To Kagaku Ryoho; 1999 Sep; 26(10):1396-400. PubMed ID: 10500525 [TBL] [Abstract][Full Text] [Related]
32. Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation. Tamaki H; Ogawa H Bone Marrow Transplant; 2004 Oct; 34(7):653-4. PubMed ID: 15258561 [No Abstract] [Full Text] [Related]
33. Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation. Urbano-Ispizua A; Brunet S; Solano C; Moraleda JM; Rovira M; Zuazu J; de La Rubia J; Bargay J; Caballero D; Díez-Martín JL; Ojeda E; Pérez de Oteiza JP; Ferrá C; Espigado I; Alegre A; de La Serna J; Torres P; Riu C; Odriozola J; Rozman C; Sierra J; García-Conde J; Montserrat E; Bone Marrow Transplant; 2001 Aug; 28(4):349-54. PubMed ID: 11571506 [TBL] [Abstract][Full Text] [Related]
34. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia]. Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801 [TBL] [Abstract][Full Text] [Related]
35. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121 [TBL] [Abstract][Full Text] [Related]
36. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990 [TBL] [Abstract][Full Text] [Related]
37. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up. Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G; Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477 [TBL] [Abstract][Full Text] [Related]
38. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse. Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011 [TBL] [Abstract][Full Text] [Related]
39. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases]. He Y; Feng SZ; Wang M; Wei JL; Qin TJ; Zhou Z; Zhai WJ; Qiu LG; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016 [TBL] [Abstract][Full Text] [Related]
40. Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures. Chávez-González A; Ayala-Sánchez M; Sánchez-Valle E; Ruiz-Sánchez E; Arana-Trejo RM; Vela-Ojeda J; Mayani H Leuk Res; 2006 Mar; 30(3):286-95. PubMed ID: 16111748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]